JPM | Free Full-Text | Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
Liraglutide as additional treatment for type 1 diabetes in: European Journal of Endocrinology Volume 165 Issue 1 (2011)
GLP-1 improves adipose tissue glyoxalase activity and capillarization improving insulin sensitivity in type 2 diabetes - ScienceDirect
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial - The Lancet
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials - Dejgaard - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study | Scientific Reports
Pharmaceuticals | Free Full-Text | Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
Victoza for People with Type 1 Diabetes?
Liraglutide plus insulin has no effect on HbA1c levels for people with type 1 diabetes, study finds - Diabetes
Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes, the ADJUNCT ONE™ treat-to-target randomised trial - Media Centre | EASD
Comparison Of The Long-Term Effects Of Liraglutide And Glimepiride Monotherapy On Bone Mineral Density In Patients With Type 2 Diabetes - Endocrine Practice
PDF) Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks
Victoza Reduces Body Fat, Increases Time in Range in Overweight Adults With Type 1 - DSM
GLP-1 Agonists Liraglutide Improved Vascular Endothelial Function in Type 2 Diabetes Rats
Liraglutide Achieves A1C Targets More often than Sitagliptin or Exenatide when Added to Metformin in Patients with Type 2 Diabetes and a Baseline A1C <8.0% - Endocrine Practice
Victoza Tested to Combat DKA for People with Type 1 | Insulin Nation
Liraglutide as add-on to insulin therapy reduces BMI, added sugar intake in obese type 1
Adjunct liraglutide use in people with type 1 diabetes in the St Vincent's Healthcare Group, Dublin: An Irish perspective - DiabetesontheNet
Liraglutide doesn't affect gastric emptying in type 1 diabetes
Frontiers | Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis
Victoza may benefit patients with type 1 diabetes, review suggests - Diabetes
Current and future therapies for type 1 diabetes | SpringerLink
